Barclays downgrades Array Technologies on weak growth outlook, margin strain
Go back to Barclays downgrades Array Technologies on weak growth outlook, margin strain| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 5.21 +0.02 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.19 | 52 Week High | $7.27 | |||
| Open | $5.18 | 52 Week Low | $2.39 | |||
| Day High | $5.25 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $-0.61 | |||
| Volume | 1,072,114 | |||||
| NYSE Arca Tech 100 ETF (NASDAQ: NXT) | Delayed: 104.23 +0.56 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.67 | 52 Week High | $25.39 | |||
| Open | $102.30 | 52 Week Low | $13.13 | |||
| Day High | $105.61 | P/E | N/A | |||
| Day Low | $101.88 | EPS | $0.00 | |||
| Volume | 252,523 | |||||
